0000895930-13-000028.txt : 20130809 0000895930-13-000028.hdr.sgml : 20130809 20130809165317 ACCESSION NUMBER: 0000895930-13-000028 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130809 ITEM INFORMATION: Other Events FILED AS OF DATE: 20130809 DATE AS OF CHANGE: 20130809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 0512 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 131027208 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD. STREET 2: SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615-665-1283 MAIL ADDRESS: STREET 1: 20 BURTON HILLS BLVD. STREET 2: SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 amsg-8k-2013-08-09.htm FORM 8-K  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 9, 2013 (August 9, 2013)

 

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)

 

Tennessee

000-22217

62-1493316

(State or Other Jurisdiction of Incorporation)

(Commission

 File Number)

(I.R.S. Employer

 Identification No.)

 

 

 

20 Burton Hills Boulevard

 

 

Nashville, Tennessee

 

37215

(Address of Principal

Executive Offices)

 

(Zip Code)

 

 

 

 

(615) 665-1283

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

        Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 8.01.      Other Events

 

On August 9, 2013, the Board of Directors of AmSurg Corp. approved a stock repurchase program pursuant to which the Company may purchase up to $40.0 million of its outstanding shares of common stock through February 9, 2015. The Company purchased all shares authorized for purchase pursuant to its prior stock repurchase program effective August 9, 2013. The purchases may be made from time to time in open market transactions, privately negotiated transactions, or otherwise (including pursuant to one or more Rule 10b5-1 purchase plans). The primary intent of the program continues to be to mitigate the dilutive effect of shares issued pursuant to the Company’s stock incentive plans. The Company intends to fund the purchase price for shares acquired using primarily cash proceeds generated from the exercise of employee stock options, cash generated from its operations and borrowings under its credit facility. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

 

SIGNATURES

 

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AMSURG CORP.

 

 

 

By:

/s/ Claire M. Gulmi

 

 

Claire M. Gulmi

 

 

 

 

 

Executive Vice President and

 

 

Chief Financial Officer

 

 

(Principal Financial and Duly Authorized Officer)

 

 

 

Date:   August 9, 2013

 

3